Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Suppl 1
|
pubmed:dateCreated |
1993-2-23
|
pubmed:abstractText |
10 patients between the ages of 5 and 40 yrs with myeloid leukemia (4 acute, 6 chronic) in early (5 cases) or intermediate stage of the disease were given Cyclophosphamide and Busulfan (6 cases) or Cyclophosphamide, Busulfan and VP-16 (4 cases with CML) and bone marrow transplants from HLA-matched donors (in 9 cases from siblings and in one case from HLA phenotypically matched father). There was one transplant related death and 3 relapses in CML cases. In cases which relapsed GvHD was not observed. Altogether acute GvH and chronic GvHD was seen in 2 and 4 cases, respectively. All grafted cases with AML survive in continuous remission lasting more than 2 years (median 30.5 month).
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-5814
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
49-59
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1488872-Adolescent,
pubmed-meshheading:1488872-Adult,
pubmed-meshheading:1488872-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1488872-Blast Crisis,
pubmed-meshheading:1488872-Bone Marrow Transplantation,
pubmed-meshheading:1488872-Busulfan,
pubmed-meshheading:1488872-Child,
pubmed-meshheading:1488872-Child, Preschool,
pubmed-meshheading:1488872-Cyclophosphamide,
pubmed-meshheading:1488872-Etoposide,
pubmed-meshheading:1488872-Graft Enhancement, Immunologic,
pubmed-meshheading:1488872-Graft vs Host Disease,
pubmed-meshheading:1488872-Humans,
pubmed-meshheading:1488872-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:1488872-Leukemia, Myeloid, Acute,
pubmed-meshheading:1488872-Transplantation, Homologous
|
pubmed:year |
1992
|
pubmed:articleTitle |
[Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
|
pubmed:affiliation |
Zespó? Przeszczepiania Szpiku Kostnego, Szpital im. Kazimierza D?uskiego.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|